Monday, January 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

PositiveID Ships Units for JUPITR Biosurveillance Program

by Global Biodefense Staff
November 19, 2014
JUPITR Biosurveillance ATD

PositiveID Corporation this week announced its highlights for the third quarter which include shipment of its M-BAND system to the Korean peninsula and Aberdeen Proving Ground for continued testing as part of the JUPITR program.

JUPITR is the Joint United States Forces Korea Portal and Integrated Threat Recognition system which will address the demand for stronger biosurveillance capabilities on the Korean Peninsula.

PositiveID reported revenue of $325,000 for the quarter ended September 30, 2014, and $745,000 for the nine months ended September 30, 2014 from their DoD subcontract to support the JUPITR program.

The company increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate to $3.6 million, and reiterated its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined).

In addition to progress with JUPITR testing, the company announced the acceleration of its Firefly Dx prototype development and engagement of Infinite Vision, an engineering development and contract manufacturing firm specializing in medical and biotech products.

PositiveID has already landed two U.S. government agreements related to Firefly Dx, a RT-PCR pathogen detection system. In October, PositiveID and its partner ENSCO were awarded a SenseNet Program contract from the US. Department of the Interior on behalf of the U.S. Department of Homeland Security to implement faster, less-expensive bio-threat detection systems, using existing infrastructure, where possible, to provide an added level of security.

Earlier this month, PositiveID announced it signed a CRADA agreement with U.S. Special Operations Command (USSOCOM) Special Operations Research, Development, & Acquisition Center, Science & Technology Directorate, to further develop Firefly Dx for use across the USSOCOM mission space.

“I am very pleased to report again that we generated revenue in the quarter and, more notably, to remind our investors of the significant progress we have made in 2014 to achieve the goals we set for ourselves related to both M-BAND and Firefly Dx,” said William J. Caragol, Chairman and CEO of PositiveID. “We are proud of the agreements we have entered into with world-class commercial and government partners, and their implicit validation of our technology and team. We believe that our accomplishments to date position us well for continued success through the end of 2014 and into 2015.”

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC